GLP-1 Medications and Dehydration: What You Need to Know One indirect kidney concern with GLP-1 therapy involves adequate hydration, since these medications reduce appetite and can slow gastric emptying, potentially decreasing fluid intake
References Reviewed Brass EP, Hiatt WR
For instance, Sermorelin may be associated with increased nocturnal growth hormone release and enhanced peak amplitude, while Ipamorelin may contribute to greater magnitude of release during stimulation
Im in my third week and have lost 7 pounds
Community protocols using 2-5 mg/kg in humans are deliberate choices by early adopters, not FDA-guided conversions
After rapid progress in weeks 8-24, the slowing rate feels disappointing even though its completely expected